Crescent Biopharma CBIO
NASDAQ CBIO
$13.92 +0.27 (+1.98%)
At close: Nov 10, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Invested Capital (2024 - 2026)

Updated

Crescent Biopharma (CBIO) recorded Invested Capital of $203.01 million in Q4 2025, up 822.7% from $22 million a year earlier and up 74.0% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Invested Capital (2024 - 2026) Analysis & Trends

Starting with Q4 2024, Crescent Biopharma's Invested Capital history includes 4 quarters.

  • Across earlier years, Invested Capital came in at $22 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Crescent Biopharma 386.36 Mn -320.93 Mn - 163.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 163.73 Mn
Mar 31, 2026 184.30 Mn
Dec 31, 2025 203.45 Mn
Sep 30, 2025 117.06 Mn
Jun 30, 2025 139.47 Mn
Dec 31, 2024 22.00 Mn
API Access

Crescent Biopharma Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=CBIO&period=max&api_key=YOUR_API_KEY